AbbVie braces for ‘greater erosion’ of Humira franchise in second half of this year

AbbVie execs touted a wave of Rinvoq programs at Cowen’s annual conference on healthcare Tuesday as they brace for a tougher Humira battle in the second half of this year.

Since its first approval in rheumatoid arthritis in 2002, Humira became one of industry’s top sellers ever, adding a...

Click to view original post